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Translational enhancementDevelopmental control of proliferation relies on tight regulation of protein expression. Although this has
been well studied in early embryogenesis, how the cell cycle is regulated during organogenesis is not well
understood. Bruno-Like RNA binding proteins bind to consensus sequences in the 3′UTR of speciﬁc mRNAs
and repress protein translation, but much of this functional information is derived from studies on mainly
two members, Drosophila Bruno and vertebrate BrunoL2 (CUGBP1). There are however, six vertebrate and
three Drosophila Bruno family members, but less is known about these other family members, and none have
been shown to function in the endoderm. We recently identiﬁed BrunoL1 as a dorsal pancreas enriched gene,
and in this paper we deﬁne BrunoL1 function in Xenopus endoderm development. We ﬁnd that, in contrast to
other Bruno-Like proteins, BrunoL1 acts to enhance rather than repress translation. We demonstrate that
BrunoL1 regulates proliferation of endoderm cells through translational control of cyclin A2 mRNA.
Speciﬁcally BrunoL1 enhanced translation of cyclin A2 through binding consensus Bruno Response Elements
(BREs) in its 3′UTR. We compared the ability of other Bruno-Like proteins, both vertebrate and invertebrate,
to stimulate translation via the cyclin A2 3′UTR and found that only Drosophila Bru-3 had similar activity. In
addition, we also found that both BrunoL1 and Bru-3 enhanced translation of mRNAs containing the 3′UTRs
of Drosophila oskar or cyclin A, which have been well characterized to mediate repression. Lastly, we show
that it is the Linker region of BrunoL1 that is both necessary and sufﬁcient for this activity. These results are
the ﬁrst example of BRE-dependent translational enhancement and are the ﬁrst demonstration in
vertebrates of Bruno-Like proteins regulating translation through BREs.Organogenesis, Institut de
a.
.
l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
In Xenopus, the endoderm is derived from the vegetal hemisphere,
andmuch is now understood about how the endodermal germ layer is
formed and how regional speciﬁcation of the endoderm is regulated
(Chen et al., 2003, 2004; Horb, 2000; Horb and Slack, 2001; Li et al.,
2008; McLin et al., 2007; Pan et al., 2007; Pearl et al., 2009). Yet the
relationship between speciﬁcation, differentiation and proliferation of
the various endodermal organs at later stages is unclear (Blitz et al.,
2006). Although much is known about cell cycle regulation during
early Xenopus development, how differentiation is coupled to the cell
cycle at tail bud and tadpole stages is unknown (Philpott and Yew,
2008). It is commonly assumed that exit from the cell cycle is required
for differentiation to proceed, but exactly at what stage in the
differentiation process this occurs has not been deﬁned. Since manycell cycle regulators (cyclins, cdk) are not ubiquitously expressed, but
rather localized to speciﬁc tissues, regulation of the cell cycle appears
to be tissue speciﬁc (Vernon and Philpott, 2003). However, which cell
cycle components control proliferation of the various endodermal
organs is unknown.
RNA binding proteins have been implicated in post-transcriptional
control of various mRNAs during embryogenesis, in particular
through sequence elements located in the 3′UTR (Kuersten and
Goodwin, 2003). One family of RNA binding proteins implicated in the
control of cell differentiation and proliferation during embryonic
development is the Bruno family (Good et al., 2000). These proteins
contain three RRM motifs and regulate RNA translation and splicing.
The founding member of this family, Bruno, was originally identiﬁed
in Drosophila based on its ability to bind the 3′UTR of oskarmRNA and
repress its translation (Kim-Ha et al., 1995). During oogenesis Bruno
regulates germline stem cells by repressing cyclin A translation, thus
permitting meiosis to proceed (Sugimura and Lilly, 2006); in bruno
mutants germline stem cells overproliferate and never enter meiosis
(Parisi et al., 2001). Bruno represses translation of speciﬁc mRNAs by
binding consensus sequences in the 3′UTR called bruno response
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brates. In planarians, a Bruno-like gene (Bruli) was found to be
expressed in neoblasts (stem cells) and required for their mainte-
nance, though exactly what mRNA(s) it regulates is not known (Guo
et al., 2006).
In vertebrates there are six members in the Bruno family, and they
are referred to as either BRUNOL (bruno-like) or CELF (CUGBP1 and
ETR-3 like factors) (Barreau et al., 2006; Good et al., 2000). In contrast
to the work in Drosophila, these proteins are found to bind CUG
repeats or AU rich elements in the 5′ or 3′UTRs of various mRNAs
(Barreau et al., 2006). In Xenopus, ﬁve of the six Bruno-Like genes have
been identiﬁed, but in most cases only their expression patterns are
known (Amato et al., 2005;Wu et al., 2010). In Xenopusmost research
has focused on BrunoL2 (also known as EDEN-BP, Embryo Dead-
enylation Element Binding Protein), which binds AU rich sequences in
the 3′UTR of various mRNAs and promotes deadenylation of these
mRNAs (Gautier et al., 2004; Paillard et al., 1998). Xenopus BrunoL1
(etr-1) was originally identiﬁed as a neural-enriched gene with
localized expression in the ventral neural tube and retina, though its
function was not studied (Amato et al., 2005; Knecht et al., 1995;
Knecht and Harland, 1997; Richter et al., 1988). In mammals, BrunoL1
(also known as TNRC4) is expressed in the developing embryo as early
as E9.5; in the adult its expression is localized to the brain and testis.
Though BrunoL1 was shown to regulate splicing of tau exon 10, mice
lacking BrunoL1 do not display any overt morphological phenotypes
(Chapple et al., 2007; Dev et al., 2007). Whether Bruno-like proteins
are expressed in the endoderm or involved in endoderm differenti-
ation has not been examined.
We recently identiﬁed BrunoL1 as a dorsal pancreas enriched gene
in a microarray comparison of dorsal and ventral pancreatic buds
(Horb et al., 2009; Jarikji et al., 2009). In this paper we describe the
functional characterization of Xenopus BrunoL1 and show that it is
directly involved in regulating cell proliferation in the endoderm. We
show that Xenopus brunol1 is expressed throughout the gastrointes-
tinal tract in a punctate fashion. Knockdown of BrunoL1 inhibited
proliferation and subsequent differentiation of almost the entire
endoderm; conversely overexpression of brunol1 resulted in an
overproliferation phenotype. We demonstrate that BrunoL1 regulates
proliferation of endodermal cells by enhancing translation of cyclin A2
mRNA by binding BREs in the 3′UTR. Last, we show that the linker
region of BrunoL1 is not only necessary for this function, but is also
sufﬁcient to confer translational stimulation activity to a known
repressor. These results are the ﬁrst example of BRE-dependent
translational enhancement and the ﬁrst demonstration in vertebrates
of Bruno-Like proteins regulating translation through BREs.
Materials and methods
Nucleic acids
Xenopus brunol1 (NM_001086467), brunol3 (NM_001086124) and
cyclin A2 (NM_001088110) cDNAs were cloned by PCR from stage 42
whole gut cDNAbased on published sequence information; brunol2was
obtained fromXDB, clone XL171c18.Drosophila bruno (LD05405), bru-2
(LD19052) and bru-3 (LD31834) were obtained from the Drosophila
Genomics Resource Center, and theORFof eachwas then subcloned into
pCS2+. To clone brunol1-FLAG, the brunol1 cDNA was cloned by PCR
amplifying brunol1 from pCS2+ using SP6 and a reverse primerwith an
NcoI site incorporated into the sequence 5′-atagcagccatggcgctgcct-3′.
PCR product was inserted into ﬂag-C107, both cutHindIII–NcoI. To clone
FLAG-brunol1, brunol1-pCRIIwas cut EcoRV and cloned into FLAG-CS107
cut XhoI (blunt). All fusions were conﬁrmed by sequencing. All mRNAs
injected intoXenopus embryosweremade from pCS2+ vector backbone
using Ambion mMessage machine kit.
The 3′ end of Xenopus cyclin A2 (BC077260), which included part of
the ORF, was cloned using the following primers: For 5′-gtgtcgattgtg-gatgaaga-3′ and Rev 5′-aatatgctaactgcctgg-3′. The 3′UTR was then
cloned downstream of gfp in the pCS2+ vector as follows: CycA2 cut
ClaI (blunt)–NotI and cloned into gfp-CS2 cut StuI–NotI. The BRE
mutant cyclin A2 3′UTR was cloned by PCR — point mutations were
included in primers used for ampliﬁcation. Primer sequences used to
introduce the mutations were For 5′-CgAatTCtgataaaagcacatgatgta-
cagttaattttttatcatataggctttggAtCGatatct-3′ and Rev 5′-ctaactgcctggt-
taattcaatctgtgcacaacagctttttaagagcaTCtaGaactaagattcaacatCTCGA-
Gaattt-3′; changes are indicated in capital letters. BREmut PCR
product cloned EcoRI-blunt into gfp-bre cut EcoRI–EcoRV. The 3′UTR
of Drosophila cyclin A (3329–3940 bp) was cloned from adult ﬂy cDNA
(a gift of D. Hipfner) into pCRII; primers used were as previously
described (Sugimura and Lilly, 2006). The 3′UTR of Drosophila oskar
(2550–3670 bp) was cloned from adult ﬂy cDNA into pCRII with the
primers: For 5′-actagttgggttcttaatcaagatag-3′ and Rev 5′ctcgagcttcga-
tagcagggac-3′. Both oskar and cycA 3′UTRs (BamHI (blunt)–NotI) were
then cloned downstream of gfp in pCS2 (StuI–NotI). For quantiﬁcation
of GFP ﬂuorescence we calculated the average ﬂuorescence intensity
and pixel area of individual embryos for each group (nN10). Each
experiment was reproduced 3 separate times and the graphs shown
are of one representative experiment.
The various domain swap clones were constructed as follows.
BrunoL1(-RRM2) was cloned by PCR as follows: the 5′ end (RRM1) was
PCR isolated fromBrunoL1-pCRIIusingT7andBL1-rev360Xhoprimer 5′-
gacagcgagagcactcgagaggaccgcaag-3′ and the 3′ end (contains linker and
RRM3) using BL1-for600Xho 5′-cacggagaaggctcgaggactgagg-3′ and SP6
and cloned into pCS2+ (EcoRI–EcoRV). BrunoL1(R2L2) containing RRM2
fromBrunoL2was clonedby PCR isolating RRM2 fromBrunoL2using the
following primers BL2-for650Xho 5′-gaataatgctcgagaagacagaaagctc-3′
and BL2-rev950Xho 5′-cgcttctgttctcgagctttctgagtg-3′ and cloning it into
the XhoI site of BrunoL1(-R2). BrunoL1(-linker) was cloned by PCR as
follows: the 5′ end (RRM1+RRM2) was PCR isolated from ﬂag-brunol1
using SP6 primer and BL1-rev600Xho 5′-cctcagtcctcgagccttctccgtg-3′
and the 3′ end (RRM3) using BL1-for1200Xho 5′-gcaacagagagaggctcga-
gagggctgcaa-3′ and T3 and cloned into pCS2+ (EcoRI–SacII). BrunoL2
(linker L1) was cloned by PCR as follows. First BrunoL2(-linker) was
cloned; the 5′ end (RRM1+RRM2) was PCR cloned from BrunoL2-CS2
using SP6 and BL2-rev650Xho 5′-gagctttctgtcttctcgagcattattc-3′ and the
3′ end (RRM3) using BL2-for1550Xho 5′-gtcagaaagaagctcgagaaggagcc-
3′ and BL2-rev1810Xba 5′-cttcccagggctctagatttcagtacg-3′. These were
ligated together into pCS2+ (EcoRI–XbaI). The linker region from
BrunoL1was then PCR cloned into theXhoI site of BrunoL2(-linker) using
the following primers BL1-for600Xho 5′-cacggagaaggctcgaggactgagg-3′
andBL1-rev1200Xho5′-ttgcagccctctcgagcctctctctgttgc-3′. All constructs
were sequenced completely to conﬁrm no mutations were present.
Whole mount in situ hybridization was performed as previously
described (Horb et al., 2003). Information regarding probes can be
found in our previous publications (Jarikji et al., 2007, 2009) and as
indicated: brunol1-pCRII (HindIII, T7); chromogranin A-pCRII (XhoI,
SP6); hnf6-pCRII (XhoI, SP6); ptf1a-pCRscript (NcoI, T7); gluc-pCRscript
(NotI, T7); Ins-pCRscript (EcoRI, T3); elas-pCMVsport6 (EcoRI, T7); Hex-
pBS (NotI, T7); secretIII-pCRscript (XhoI, T3); Insm1-pCRII (HindIII, T7);
ngn3-pBS (EcoRI, T3); Nkx2.2-pBS (NotI, T7); pax6-pCDNA3 (SmaI,
SP6); neurod-pBS (XhoI, T7); frp5-pCRII (NotI, SP6). Double in situ
hybridizations were done as described (Horb and Slack, 2002; Horb
and Thomsen, 1999). Whole mount immunostaining with anti-
phosphohistone H3 antibody was carried out as described (Saka and
Smith, 2001). Histology was performed as described (Horb and
Thomsen, 1997). Expression of each marker was examined in brunol1
morphant whole guts from at least 3 separate experiments.
Morpholinos
Antisense morpholino oligonucleotides were designed by and
purchased from Gene Tools, LLC. Speciﬁcity was conﬁrmed by in
vitro transcription and translation for each gene and morpholino.
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eight-cell stage, targeting the stomach, liver and pancreas. Proper
targeting was conﬁrmed by monitoring ﬂuorescence from labeled
morpholino oligonucleotides after dissection of whole guts. Only those
showing even ﬂuorescence in these organs were used for analysis. The
brunol1 morpholino sequences were: brunol1-utr 5′-gagcagagaaggaa-
cagactctcac-3′, brunol1-start 5′-gtttgatggcatctggttccttcat-3′ andbrunol1-
mismatch 5′-CagcaCagaaCgaaGagaGtctGaG-3′.
Protein
To conﬁrm speciﬁcity of morpholino binding to mRNA we
performed TnT assays using the TNT-coupled reticulate lysate system
(Promega) with 500 ng of cDNA (brunol1-ﬂag) and 500 ng of
antisense or mismatch morpholino; 5 μl of the reaction was then
used for western blot analysis using a polyclonal anti-ﬂag antibody
(Sigma) to detect BrunoL1 protein. For co-immunoprecipitations
neurula stage 15 embryos were homogenized in lysis buffer (150 mM
NaCl, 50 mM Tris, 1% Triton, 10 mM EDTA and 1× Complete Protease
Inhibitor Tablet (Roche)), sonicated and cleared by centrifugation at
15,000 rpm at 4 °C. M2 anti-Flag beads (Sigma) were then added to
the cleared lysates and incubated with rotation for 2 h at 4 °C; the
beads were then washed extensively in lysis buffer, and divided into
two pools. One half was used for Western Blot Analysis to conﬁrm
immunoprecipitation, the other half was added to Trizol (Invitrogen)
to isolate total bound RNA. cDNAwas then synthesized using oligo-dT
and superscript RT (Invitrogen), and PCR carried out with primers as
follows: gfp (25 cycles) For 5′-tacagctcgtccatgccatg-3′ and Rev 5′-
gaagtcaagttcgaaggtga-3′; cycA2 (25 cycles) For 5′-aagatggag-
catctggtgct-3′ and Rev 5′-gagaggtaggtctggtatag-3′; edd primers
were as previously described (Horb and Slack, 2001). Analysis of
endogenous Cyclin A2 protein in brunol1mRNA injected embryoswas
done as follows: 400 pg of brunol1 was injected into 8 cell stage
embryos and at stage 15 protein extract was isolated from groups of
4 embryos (control and brunol1). One embryo equivalent was loaded
onto the gel and endogenous Cyclin A2 protein levels were deter-
mined using the monoclonal anti-cyclin A2 antibody (1:200; a gift of
Tim Hunt).
To quantify the total GFP ﬂuorescence we acquired the color
images (8-bits per channel) using a Color camera DFC450 from Leica.
The green channel was extracted from the color image. Normalized
ﬂuorescence values were obtained by the following procedure. Pixels
were initially selected from the 8 bits grayscale (green channel) image
using a threshold value (set to 13). The sum of selected values was
obtained from at least 10 embryos for each group. Sums of images
were average along the same sample type. Average values were
normalized against the control type giving Fold stimulation.
Results
Xenopus BrunoL1 was originally isolated as a neural-enriched gene
(named etr-1) localized to the ventral neural tube (Knecht et al.,
1995); whether it was expressed in the endoderm was not examined.
Since our recent microarray identiﬁed brunol1 as being expressed in
the pancreas, we examined its endodermal expression in detail.
Expression of brunol1 was ﬁrst detected in the dorsal endoderm in
only a few cells beginning at NF32 (Fig. 1A). By NF35 expression
extended to more lateral endoderm, but was conﬁned to the outer
layer of cells (Fig. 1B). At NF39 expression was now detected
throughout the endoderm in scattered cells (Fig. 1C). Within the
pancreas, we found to be localized to the dorsal pancreas at NF40
(Fig. 1D). By NF42/44 brunol1 expression was now found in both
dorsal and ventral portions of the pancreas (Fig. 1E). In addition to the
pancreas, we found brunol1 to be expressed throughout the entire
gastrointestinal tract at all stages, but absent from the liver (Figs. 1G,
H). Although this punctate staining pattern is reminiscent of that seenwith endocrine-speciﬁc markers, brunol1 was not expressed in
differentiated endocrine cells. Brunol1 was not co-expressed with
either insulin, whichmarks pancreatic beta cells, or with chromogranin
A, which marks both gastrointestinal and pancreatic endocrine cells
(Figs. 1F, I). Furthermore, the temporal distribution of brunol1 within
the pancreas is vastly different from all other endocrine-speciﬁc
genes. Pancreatic endocrine differentiation markers remain localized
to the dorsal pancreas until NF46/47, at which time their expression is
also foundwithin the portion of the pancreas derived from the ventral
pancreatic bud (Horb and Slack, 2002). In contrast, ventral pancreas
expression of brunol1 is detected quite early, beginning at NF42/43,
several days before other endocrine differentiation markers.
This lack of co-expression with known endocrine cell markers
raised the question of which cell types in the pancreas and endoderm
were expressing brunol1. Our results presented below led us to
conclude that brunol1 was expressed in cells undergoing prolifera-
tion. Therefore, we compared the expression proﬁles of brunol1 and
proliferating cells. Using a phosphohistone H3 antibodywe stained for
proliferating cells from early tadpole stages, NF32, through to late
stages in isolated whole guts and liver/pancreas tissue, NF45. We ﬁrst
detected pH3 staining in the endoderm beginning at NF32, and only in
a few scattered cells in the dorsal endoderm in the same region as
brunol1 (data not shown). By NF35, scattered proliferating cells could
now be detected in slightly more lateral regions (Fig. 1J). By NF39
abundant pH3 staining cells were now detected throughout the entire
endoderm (Fig. 1K). Within the pancreas at NF40, proliferating cells
were only detected within the dorsal pancreas (Fig. 1L). Shortly
thereafter, by NF42 proliferating cells were also seen in the ventral
pancreas derived tissue (data not shown). As expected pH3 staining
marked a larger population of cells than brunol1 did. At early tadpole
stages, mesoderm cells stained were pH3 positive, while in later stages
the liver also contained abundant proliferating cells (see Figs. 1J, L). This
temporal and spatial proﬁle of pH3 staining within the early endoderm
and in the pancreas was almost identical to that seen for brunol1
suggesting that brunol1 was perhaps expressed in progenitor cells
undergoing proliferation, and our functional data below supports this
possibility.
To investigate whether brunol1 was necessary for endoderm
development we created a knockdown phenotype using antisense
morpholinos. Two antisense morpholinos were designed to the 5′UTR
and translation start and injected (20 ng) into dorsal-vegetal
blastomeres at the eight-cell stage targeting the anterior endoderm.
(Both morpholinos gave identical results, but only results from the 5′
UTR morpholino are presented throughout the paper.) We only
targeted the anterior endoderm since embryos injected into all four
vegetal blastomeres were severely growth retarded and died at early
tadpole stages, most likely due to neural tissue effects where brunol1
is highly expressed. A 7 bp mismatch morpholino was used as a
control and speciﬁcity was determined by in vitro transcription and
translation (Fig. 2A). Embryos injected with the antisense brunol1
morpholino developed normally to tadpole stages with no overt
defects. However, beginning at NF40/41 we noticed that the stomach,
duodenum and pancreas all appeared smaller; this phenotype was
observed in 100% of embryos where the morpholino was targeted to
the anterior endoderm (n=60).
At early tadpole stages, NF35, we found normal expression of ptf1a,
hnf6 and pdx1 in brunol1 knockdown tadpoles indicating that
patterning of the anterior endoderm was normal (Figs. 2B–E and
data not shown). These results were also conﬁrmed by real time PCR
(data not shown). In addition, we found expression of the endocrine
progenitor marker, insm1, to be normal in the pancreatic endoderm at
NF32, suggesting that initial development of endocrine beta cells
was unaffected (Figs. 2F, G). However, by NF40/41 expression of
endocrine-speciﬁc progenitor markers (ngn3 and insm1) was com-
pletely absent in both the gastrointestinal tract and pancreas
(Figs. 2H–K). Expression of endocrine differentiation transcription
Fig. 1. Expression of brunol1 in developing endoderm. (A–C) Expression of brunol1 in tadpoles at NF32, NF35 and NF39. A few scattered cells expressing brunol1 are detected at stage
32 in the extreme dorsal endoderm. By stage 35 expression can now be detected in more lateral endoderm. (D) NF41 isolated pancreas/liver tissue. At this early stage, brunol1 is
expressed in a punctate pattern only in the dorsal pancreas. (E) NF44 isolated pancreas/liver. Expression of brunol1 is now detected throughout the entire pancreas. (F) Double in situ
hybridization of brunol1 (purple, arrow) and insulin (red, arrowhead) in NF44 isolated pancreas/liver. No overlap in expression is seen. Insulin expression is conﬁned to the dorsal
pancreas, whereas brunol1 expression is also present in the ventral part of the pancreas. (G,H) NF41 and NF44 isolated whole gut. Expression is punctate throughout the entire
gastrointestinal tract. (I) Double in situ hybridization of isolated whole gut for chromogranin A (red, arrowhead) and brunol1 (purple, arrow). No overlap in expression is seen.
Chromogranin A is expressed in all differentiated endocrine cells. (J) pH3 staining at NF32. Expression in the endoderm is only detected in scattered cells (arrowhead). Mesodermal
expression is also detected. (K) pH3 staining at NF39. Proliferating cells are found throughout the entire endoderm, similar to brunol1. (L) pH3 staining at NF40 in isolated liver/
pancreas tissue. Proliferating cells are only found in the dorsal pancreas (line demarcates dorsal versus ventral portions of the pancreas). Proliferating cells are also found in the liver.
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but some expression was still detected in the pancreas (Figs. 2L–O).
The normal expression of early insm1 and the persistent expression of
neurod and pax6 in the pancreas at later stages suggested that
differentiation of beta cells (ﬁrst pancreatic endocrine cells to develop
in Xenopus) was normal.
In agreementwith this we found normal expression of the beta cell
marker insulin at stage 40/41 (Figs. 3A, B). In contrast, we were unable
to detect expression of glucagon (gcg) or somatostatin (som) in the
stomach/duodenum (Figs. 3C, D and data not shown). And at later
stages, when som and gcg are expressed in the pancreas, we also did
not detect expression of either marker (data not shown). Similar to
the endocrine pancreas, we found differentiation of the exocrine
pancreas to also be inhibited. Expression of the late acinar differen-
tiation marker elastase was reduced (Figs. 3E, F), whereas there was
normal expression of the early acinar marker XPDIp (data not shown).
Althoughwe cannot explain the reason for these differential effects on
acinar markers, we believe it may be due to the temporal distinctions
seen between XPDIp and elastase. Since XPDIp is expressed earlier
than other acinar differentiation markers and in a broader domain, it
may mark acinar cells in an earlier state of differentiation. In addition
to the defects in the pancreas, we also found diminished expression
of the general stomach/duodenum marker frp5 (Figs. 3G, H). Inagreement with the fact that brunol1 was not expressed in the liver
we found normal expression of hex (Figs. 3I, J). These results showed
that brunol1was essential for differentiation of most of the endoderm,
but not for liver or pancreatic beta cells.
To examine how loss of BrunoL1 could affect differentiation of
almost every endodermal cell population, we examined whether
proliferation was affected in the endoderm of BrunoL1 knockdown
tadpoles. In control whole guts at NF41, abundant phosphohistone H3
staining is seen throughout thegastrointestinal tract,while in endoderm
lacking brunol1 we saw a large reduction in phosphohistone H3
(Figs. 3M, N). To quantify this effect, we counted the total number of
phosphohistone H3 cells within the stomach/duodenum region of both
control and brunol1morphants (Figs. 3M, N brackets). In control whole
guts, there were an average of 25 positive cells, while in the brunol1
morphants therewere only 13; analmost50%decrease (Fig. 3O, n=19).
A similar reduction was also seen inmore posterior endoderm that was
targeted by the brunol1 morpholino, while areas not targeted by the
morpholino showed normal pH3 staining (data not shown). These
results demonstrated that loss of BrunoL1 resulted in reduced
proliferation of endodermal cells. That proliferation of pancreatic beta
cells is regulated differently than other endocrine cells is supported by
the fact that cdk4 was found to be required only for beta cell pro-
liferation, and not other endocrine cell types (Rane et al., 1999).
Fig. 2. Endodermal patterning occurs normally in BrunoL1 knockdown tadpoles. (A) In vitro transcription translation reactions. Translation of BrunoL1 is blocked in the presence of
the antisense morpholino, but not the mismatch morpholino. (B,C) Ptf1a expression in control and BrunoL1 depleted tadpole showing normal induction of dorsal and ventral
pancreatic buds (n=10). (Arrows point to the dorsal and ventral pancreatic buds that express Ptf1a.) (D,E) Hnf6 expression is also normal in BrunoL1 knockdown tadpoles (n=10).
(F,G) Insm1 expression in the dorsal pancreas at stage 32 is normal in brunol1 morphants (n=10). (H,I) Expression of the endocrine progenitor marker insm1 (n=17) is reduced in
both the pancreas and gastrointestinal tract. (J–M) Both neuroD (n=23) and pax6 (n=23) are also reduced, but some expression can be detected in the pancreas, most likely
marking those beta cells that are present. Whole guts are from stages 41/42. In all panels the pancreas is outlined. (N,O) Trace drawings of panels J and K to illustrate the different
organs.
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inhibition of endogenous BrunoL1 we attempted to rescue the
morpholino-induced phenotype through co-injection of a ﬂag-brunol1
mRNA lacking the 5′UTR sequence to which the antisense morpholino
was designed. Co-injection of 200–300 pg of ﬂag-brunol1 mRNA was
sufﬁcient to rescue the differentiation of anterior endoderm as judged
by expression of elastase (elas). In control embryos, the pancreas is of
normal size and abundant elas expression is detected in the pancreas
(Fig. 4A). In morpholino-injected embryos, expression of elas was
reduced in 100% of injected samples (Fig. 4B, n=43). In embryos
injected with the morpholino and ﬂag-brunol1 mRNA the size of the
pancreas and elas expression were restored in 71% of injectedembryos (Fig. 4C, n=38). When higher doses of ﬂag-brunol1 were
injected we observed an overexpression phenotype as discussed
below. These results demonstrate that the morpholino-induced
phenotype is directly due to the loss of BrunoL1.
Based on these results, we concluded that if BrunoL1 was involved
in regulating endodermal proliferation, then ectopic expression
should produce a phenotype. To test this, we injected brunol1
mRNA into vegetal blastomeres of eight-cell embryos. Beginning at
NF40, when the pancreas, liver, and stomach are apparent, we noticed
two different phenotypes: ectopic pancreas and overgrowth of more
posterior foregut endoderm (Fig. 5). The ectopic pancreas was the
most common phenotype that resulted in the pancreas growing on
Fig. 3. BrunoL1 is essential for endodermal cell differentiation. (A,B) Expression of insulinwas normal in the pancreas of brunol1 morphants (n=15). (C,D) Expression of glucagon in the stomach/duodenum is reduced (n=23). Similar results
were found for somatostatin (n=20). (E,F) elastase expression was reduced (n=16). (G,H) Similarly, there was reduced expression of the general stomachmarker, frp5 (n=14). (I,J) Liver development was normal as assessed by expression
of hex (n=12). (K,L) Trace drawings of panels G and H. The pancreas is outlined in panels A–D, F, and I–J. (M) Control NF41 whole gut stained for phosphohistone H3 to mark proliferating cells. (N)Whole gut from brunol1 morphant stained
for phosphohistone H3. Note the large decrease in proliferating cells, especially apparent in the stomach and duodenum. (O) Average number of proliferating cells within the stomach of 10 different whole guts from control and morpholino-
injected. (Error bars represent standard deviation.) We only counted the number of cells in the stomach/duodenal area, even though the morpholino was targeted to a larger region, including more posterior endoderm. To ensure that
equivalent areas were compared we counted cells in control and morpholino samples within the same deﬁned total area. A reduction in pH3 staining was also seen in the other targeted regions, but for quantiﬁcation we only focused on the
stomach/duodenal region. Areas not targeted by the morpholino (i.e. no ﬂuorescence) showed normal pH3 staining.
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Fig. 4. Flag-BrunoL1 mRNA rescues the morpholino knockdown phenotype. (A) Control NF42 whole gut stained for elastase mRNA showing expression in the pancreas. (B) Whole
gut from embryo injected with 15 ng of brunol1 morpholino. Elastase expression is almost completely lost in injected embryos (n=43). (C) Isolated whole gut stained for elastase
expression from embryo injected with 15 ng of brunol1 morpholino and 200 pg of ﬂag-brunol1 mRNA. Elastase expression was restored in 27/38 embryos.
162 L.D. Horb, M.E. Horb / Developmental Biology 345 (2010) 156–169the ventral side of the stomach (Figs. 5A–F). These ectopic pancreatic
cells expressed elastase, but not insulin or other general endocrine
markers (Figs. 5C–F and data not shown). The overgrowth of more
posterior endoderm appeared as large bulges growing out of the
endoderm (Figs. 5G, H). We next examined histological sections to
conﬁrm the expansion of pancreatic tissue in these samples. Com-
parison of serial sections of whole guts from control and brunol1
mRNA injected samples conﬁrmed the development of ectopic
pancreas in brunol1-injected embryos. In control samples the
pancreas is found to lie between the stomach/duodenum and
intestine (Figs. 6A–D). At its longest point control pancreatic tissue
extends 180° around the stomach/duodenum (Fig. 6B). In contrast, inFig. 5.Overexpression of brunol1 results in an overproliferation phenotype. Enlarged pancrea
blastomeres at the eight-cell stage. (A,B) ptf1a expression (n=12). Arrow points to the ecto
Pancreas is outlined. (E,F) elastase is expressed in the ectopic pancreatic tissue (arrow, n=23
of the liver marker hex is normal, though the liver does appear a little larger (n=14). (K,L)
tadpoles injected with brunol1 mRNA.brunol1-injected whole guts pancreatic tissue extends around the
entire stomach/duodenum (Figs. 6E–H). These overexpression results
agreed with the loss-of-function data and showed that BrunoL1 is not
only necessary, but also sufﬁcient for endodermal cell proliferation.
BrunoL1 controls proliferation through translational regulation of cyclin
A2
This effect on proliferation suggested that Xenopus BrunoL1 was
regulating endodermal cell proliferation through translational control
of speciﬁc cell cycle mRNAs, analogous to how Drosophila bruno
regulates translation of cyclin A during oogenesis. However, since thes phenotype seen in embryos injectedwith brunol1mRNA injected into 2 dorsal-vegetal
pic pancreas. (C,D) No expression of insulin is detected in the ectopic pancreas (n=24).
). (G,H) frp5 expression is normal (n=10). Arrow points to overgrowth. (I,J) Expression
Trace drawing of panels A and B illustrating the overgrowth of pancreatic tissue in the
Fig. 6. 3-D reconstruction of brunol1 overexpression phenotype. Serial histological sections were taken from control and brunol1 injected NF44 whole guts. Color overlays added to
help visualize differences (Blue—pancreas, yellow—gut endoderm, pink—liver). (A–C) Representative sections of control whole guts. (D) 3-D reconstruction of control whole guts
using Amira software. Notice that the pancreas does not encircle the duodenum. (E–G) Representative sections of whole guts isolated from tadpoles injected with brunol1 mRNA.
(H) 3-D reconstruction reveals increased amounts of pancreatic tissue such that it now encircles the duodenum. Blue—pancreas, yellow—gut endoderm, pink—liver.
163L.D. Horb, M.E. Horb / Developmental Biology 345 (2010) 156–169loss-of-function effects of Drosophila bruno (overproliferation) and
Xenopus brunol1 (decreased proliferation) were opposite, we hypoth-
esized that Xenopus BrunoL1was acting to stimulate translation of cell
cycle mRNAs rather than repress. To test this hypothesis we examined
whether BrunoL1 was involved in translational regulation of cyclin A.
(In Xenopus there are two cyclin A homologues, but only cyclin A2was
found to be expressed in the gut endoderm (data not shown).) We
cloned the cyclin A2 3′UTR downstream of the GFP open reading frame
(gfp-bre) and injected this mRNA alone or with brunol1mRNA into the
vegetal hemisphere of Xenopus embryos (Fig. 7A). Injection of this gfp-
bre mRNA alone resulted in low levels of GFP ﬂuorescence at neurula
stages (Fig. 7B). However, co-injection of brunol1mRNA resulted in a
5-fold increase in GFP protein ﬂuorescence (Figs. 7C, F). Since the
ability of Drosophila Bruno to repress translation is mediated by
consensus sequences located in the 3′UTR of these mRNAs called
bruno response elements (BRE) we examined whether Xenopus
BrunoL1 enhanced translation of cyclin A2 by binding BRE elements
in the 3′UTR. We searched the cyclin A2 3′UTR for bruno response
elements (BRE) and found three BREs (Fig. 7A). To determine whether
the increased translation of gfp-bre by BrunoL1 was due to it binding
these BREs, we made point mutations in all 3 BRE sites (gfp-bremut).
Similar to gfp-bre mRNA, low-level GFP ﬂuorescence was observed in
embryos injected with gfp-bremut mRNA alone (Fig. 7D). However,
co-injection of brunol1mRNAwith gfp-bremutmRNA did not result in
increased GFP protein expression (Figs. 7E, F). These results
demonstrated that BrunoL1 was sufﬁcient to increase translation of
an heterologousmRNA containing the 3′UTR of cyclin A2, and that this
activity was BRE-dependent.
Wenext examinedwhether BrunoL1was in a complex that bound to
the 3′UTR of cyclin A2mRNA. Flag-brunol1mRNAwas co-injected along
with gfp-bre or gfp-bremut mRNAs into eight-cell embryos and at
neurula stages the BrunoL1-mRNA complex was immunoprecipated.
Total RNAwas then extracted from the immunoprecipitate and RT-PCR
used to determinewhether gfp-bremRNAwas associatedwith BrunoL1.
When gfp-bremRNA was injected with ﬂag-brunol1, the gfp-bremRNA
co-immunoprecipitated with Flag-BrunoL1 protein (Fig. 7G). However,
when gfp-bremut mRNA was co-injected with ﬂag-brunol1 we did not
detect an associationwith BrunoL1. Expression of the general endoderm
marker, Edd, served as our control and was detected in the total RNA
fractions, but not in the immunoprecipitated fractions (Fig. 7G). Since
the gfp-bre mRNA we used was an exogenously injected mRNA weexamined whether BrunoL1 associated with endogenous cyclin A2
mRNA. Using primers speciﬁc for endogenous cyclin A2 open reading
frame, we were able to show that cyclin A2mRNA was bound by Flag-
BrunoL1 (Fig. 7G). Endogenous cyclin A2 was also detected in the
BrunoL1 complex immunoprecipitated from the BREmut+BrunoL1
samples (Fig. 7G). We also found increased levels of endogenous Cyclin
A2 protein in brunol1 injected embryos as compared to control
(Fig. 7H). These results showed that BrunoL1 bound endogenous cyclin
A2 mRNA and enhanced translation leading to increased amount of
Cyclin A2 protein.
Two possible explanations for the increased translation of gfp-bre
mRNA by BrunoL1 is either mRNA stability or translational activation.
In the ﬁrst instance BrunoL1 would bind gfp-bre mRNA and stabilize
the mRNA, preventing degradation and leading to increased transla-
tion. In the second instance BrunoL1 would bind gfp-bre mRNA and
promote increased translational efﬁciency without affecting gfp-bre
mRNA degradation. To differentiate between these two possibilities
we examined whether the degradation of gfp-bre mRNA was altered
in the presence of BrunoL1. Equal amounts of gfp-bre (or gfp-bremut)
mRNA were injected either alone or in combination with brunol1
mRNA. Immediately after injection embryos were collected to
establish the initial amount of gfp-bre mRNA injected. At neurula
stage 15 a second set of embryos was collected; at this stage increased
GFP protein is evident in the brunol1+gfp-bre embryos. Using RT-
PCR, we compared the amounts of gfp-bre mRNA present in each
fraction and normalized the levels to eEF1A, but found no difference in
the levels of gfp-bremRNA (data not shown). This demonstrated that
BrunoL1 did not act to increase the stability of gfp-bre mRNA.
Linker region of BrunoL1 is responsible for its ability to increase translation
The ability of BrunoL1 to increase translation was surprising since all
previous data on Bruno-like proteins in Drosophila and vertebrates
showed that this family of proteins acted to repress translation. We
therefore examined whether this ability to increase translation was a
general characteristic of Bruno-Like proteins.We tested the ability of two
other Xenopus Bruno-Like proteins (BrunoL2 and BrunoL3) and three
Drosophila Bruno proteins (Bruno, Bru-2 and Bru-3). Of these, only
Drosophila Bru-3 stimulated translation of gfp-bre mRNA, though it was
not as efﬁcient as BrunoL1 (Figs. 8A–I and data not shown). Similar to
XenopusBrunoL1we found the ability of DmBru-3 to enhance translation
Fig. 7. BrunoL1 function is dependent on BREs in the 3′UTR. (A) Schematic diagram illustrating the sequence of the 3 BREs in the 3′UTR of cyclin A2 and the respective point
mutations made. (B) Injection of gfp-bre resulted in a low level of GFP ﬂuorescence. (C) Co-injection of brunol1 increased GFP ﬂuorescence in 78% of embryos (n=67). (D) Injection
of the gfp-bremutmRNA produced a similar low-level ﬂuorescence as seen with the gfp-bremRNA. (E) No increase in GFP ﬂuorescence was seen when brunol1was co-injected with
gfp-bremutmRNA (n=17). (F) Quantiﬁcation of GFP ﬂuorescence. Injection of brunol1 mRNA along with gfp-bre resulted in a 5-fold increase in GFP ﬂuorescence. For details on how
we calculated fold stimulation see materials and methods. Experiment repeated at least 3 times. (G) RT-PCR detection of gfp, edd and cyclin A2 from total RNA of injected embryos
(1st four lanes) or from total RNA after immunoprecipitation using ﬂag antibody (2nd four lanes). gfpmRNAwas immunoprecipated in the presence of Flag-BrunoL1 protein, but not
when the BRE sites were mutated (BREmut+BrunoL1). Edd was used as a control, and was detected in total RNA, but not in the immunoprecipitated RNA. Endogenous cyclin A2
mRNAwas detected in both lanes where BrunoL1 was immunoprecipitated. (H) Levels of endogenous Cyclin A2 protein in control and brunol1 injected embryos, demonstrating that
there was increased Cyclin A2 protein levels in brunol1 injected embryos.
164 L.D. Horb, M.E. Horb / Developmental Biology 345 (2010) 156–169wasmediated by BRE sequences, as it was unable to enhance translation
of the gfp-bremutmRNA (data not shown). Last, we examined whether
this activity was speciﬁc to the cyclin A2 3′UTR or found with any BRE
containing 3′UTRs.We tested the 3′UTRs ofDrosophila cyclin A and oskar,
both of which have been well characterized as targets for Drosophila
Bruno repression (Kim-Ha et al., 1995; Sugimura and Lilly, 2006).
Interestingly, we found both Xenopus BrunoL1 and Drosophila Bru-3 able
to increase translationofgfp-Dmoskarand gfp-DmcycAmRNAs inXenopus
embryos (Figs. 8E–H and data not shown). These results demonstrate
that the ability to increase translation of mRNA targets is not a general
characteristic of every Bruno-Like protein, but is limited to BrunoL1 and
Bru-3 and is BRE-dependent.
To delineate which domain of BrunoL1 was responsible for this
effect, we individually removed and/or replaced different domains of
BrunoL1 (RRM motifs and the linker region) with the corresponding
region from BrunoL2, which did not increase translation of gfp-bre
mRNA. We tested the ability of these new chimeric proteins to
enhance translation of gfp-bre mRNA. As before, co-injection of
brunol1 increased total GFP protein ﬂuorescence over 2.5-fold
(Fig. 8K). Replacement (or removal) of the second RRM with the
BrunoL2 RRM (BrunoL1 (R2L2)) did not have any effect, whereas
removal of the BrunoL1 linker region (BrunoL1 (-link)) completely
abolished the translational enhancement activity of BrunoL1 (Fig. 8K
and data not shown). When we replaced the BrunoL2 linker domain
with the BrunoL1 linker (BrunoL2 (link L1)) we found that this new
chimeric protein was able to stimulate translation of gfp-bre mRNA(Fig. 8K). In conclusion, we found that the linker region was both
necessary and sufﬁcient to stimulate translation.
Based on our results we propose the followingmodels to account for
BrunoL1 function. The standard closed loop model of translational
regulation via the 3′UTR by RNA binding proteins involves the
establishment of a preinitiation complex that then recruits the 40S
ribosome resulting in translational activation (Fig. 9A). Several different
mechanisms have been identiﬁed that block the formation of this
preinitiation complex resulting in translational repression. For example,
Drosophila Bruno represses translation by binding BRE sites in the 3′UTR
of oskar and recruiting the protein Cup (through the linker domain),
which then binds eIF4E (Fig. 9B). This action prevents eIF4G from
binding. There are two possible models to explain our results with
BrunoL1. In the ﬁrst, BrunoL1 binds BREs in the 3′UTR of cyclin A2 and
directly interacts with eIF4G through its linker domain leading to the
establishment of the preinitiation complex and translational activation
(Fig. 9C). In the second model, the linker domain of BrunoL1 interacts
with an intermediary protein (protein X), which then recruits eIF4G
(Fig. 9D). Since it is the linker domain that speciﬁes translational
repression versus activation itwill be interesting to identify the proteins
that bind the BrunoL1 linker domain.
Discussion
In this paper we identiﬁed a new function for BrunoL1 in
endoderm development. We demonstrated that brunol1 is expressed
165L.D. Horb, M.E. Horb / Developmental Biology 345 (2010) 156–169throughout the endoderm in a punctate fashion and that it was
required for proliferation of most endodermal cells. We show that
BrunoL1 binding to the 3′UTR of cyclin A2mRNA resulted in increased
translation, whichwas dependent on three consensus Bruno Response
Elements (BREs). Lastly, we identiﬁed the linker domain of BrunoL1 as
necessary for its ability to stimulate translation, and we showed that
this domain was also sufﬁcient to confer this ability to BrunoL2. These
results are the ﬁrst example of BRE-dependent translational enhance-
ment and the ﬁrst to demonstrate BRE-dependent translational
regulation in vertebrates.Fig. 8. Linker region is essential for BrunoL1 to increase translation. (A–H) Representative im
or Drosophila Bru-3 mRNA. Top row gfp mRNA contains the Xenopus cyclin A2 3′UTR (GFP-b
stimulation of GFP ﬂuorescence over gfp-bre mRNA alone. (J) Schematic diagram illustratin
proteins were either removed or replaced with the corresponding region from other Bruno-L
BrunoL2 RRM2. BrunoL1 (-link) indicates that the linker region was removed from BrunoL
BrunoL1 linker domain. Fold stimulation was then calculated.BrunoL1 in endoderm development
Our study is the ﬁrst to describe a function for Bruno-like genes in
endoderm development. The function of other RNA binding proteins
in the context of endoderm development has not been studied in
detail though a few examples have been published. In Xenopus, the
KOC (K-homologous domain containing protein overexpressed in
cancer) homologue, Vg1RBP, is essential for pancreas development
(Spagnoli and Brivanlou, 2006). And in zebraﬁsh nil per os (npo) was
shown to be required for exocrine pancreas development and gutage of a single embryo injected with gfp mRNA alone or with Xenopus BrunoL1, BrunoL2
re) and the bottom row gfp is fused to the Drosophila oskar 3′UTR (GFP-Oskar). (I) Fold
g the various domains of Bruno-Like proteins. (K) Different domains of the Bruno-Like
ike proteins. BrunoL1 (R2L2) indicates that the RRM2 in BrunoL1 was replaced with the
1. BrunoL2 (link L1) indicates that the linker region of BrunoL2 was replaced with the
Fig. 8 (continued).
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binding proteins regulate endoderm development and their mRNA
targets remains to be elucidated.
Whereas these RNA binding proteins were found to affect speciﬁc
cell types, we found BrunoL1 to be a global regulator of endodermal
cell proliferation. Of interest is the fact that BrunoL1 does not regulate
proliferation of pancreatic beta cells and the liver. The reason for this
difference is unclear, though it is known that beta cell proliferation is
regulated differently than other endocrine cell types; cdk4was shown
to be required only for beta cell proliferation, and not other endocrine
cell types (Rane et al., 1999). Yet, we did ﬁnd that both pancreatic beta
cells and liver cells required cyclin A2 for proliferation (data not
shown). This suggests that another, yet to be deﬁned RNA binding
protein(s) regulates cyclin A2 translation in these cell types. In this
regard, the related RNA binding protein HuR and Wilms' tumor 1-
associated protein (WTAP) have both been shown to stabilize cyclin A
mRNA through its 3′UTR (Horiuchi et al., 2006; Wang et al., 2000). It
will be interesting to ascertain whether other RNA binding proteins
play a role in regulating cyclin A2 translation within the endoderm.Dorsal pancreas speciﬁc genes
Since many of the other dorsal pancreas enriched genes identiﬁed
in our dorsal–ventral pancreatic bud microarray were endocrine-
speciﬁc genes (Horb et al., 2009; Jarikji et al., 2009), we expected
brunol1 to also be expressed in endocrine cells and play a role in
endocrine cell differentiation, and its speckled expression pattern did
initially suggest this. However, we did not ﬁnd it to be co-expressed
with any endocrine markers, and our functional data demonstrated
that brunol1 regulated proliferation of a larger subset of endodermal
cells. This implies that the dorsal pancreas is composed of more than
just endocrine cells. The fact that endocrine-speciﬁc genes are
expressed in only a small population of the dorsal pancreas (speckled
pattern) and not uniformly distributed agrees with this idea. Most
likely there are several different populations of cells within the dorsal
pancreas, which have yet to be characterized.We believe that brunol1 marks one such population. In agreement
with this, the temporal expression changes of brunol1 in the pancreas
are quite different from that seen with other endocrine markers.
Expression of other pancreatic endocrinemarkers is initially localized to
the dorsal pancreas, and expression in the ventral portion of the
pancreas is not seen until after stage 45. In contrast, brunol1was found
expressed in the ventral pancreas as early as stage 42. This lack of co-
expressionwith endocrinemarkers suggested that brunol1wasmarking
a separate population of cells within the endoderm, most likely
proliferating cells. In agreement with this, we found a direct correlation
between the temporal and spatial expression patterns of brunol1 and
proliferating cells (see Fig. 1). Initially phosphohistone H3 staining cells
are only detected in scattered cells in the dorsal endodermatNF32,with
expression extending to more lateral and ventral regions by NF35, with
abundant staining throughout the endoderm at NF39. This pattern was
identical towhatwas seenwith brunol1.Within the pancreas, we found
proliferating cells initially only in the dorsal pancreas at NF40, with
expression rapidly extending to the ventral pancreas by NF42. We
believe that BrunoL1 is expressed in proliferating cells, and this would
explain why knockdown of BrunoL1 has such drastic effects on the
developing endoderm.
Differential effects of brunol1 loss on endodermal differentiation
Our results showed that knockdown of Brunol1 blocked differenti-
ation of almost every endodermal cell type, except for liver and
pancreatic beta cells. The lack of an effect on the liver is explained by the
fact that brunol1 is not expressed in hepatic endoderm,while the effects
onpancreatic beta cells seemcontradictory. The reason for this apparent
contradiction is, that at ﬁrst glance, that expression of brunol1 seems to
parallel insulin expression.Upon closer examination however, this is not
the case. Expression of brunol1 in the dorsal pancreas only begins after
beta cells have differentiated. Insulin expression is ﬁrst detected in the
dorsal endoderm as early as stage 28, whereas expression of brunol1 is
only detected beginning at stage 32. In agreement with this, we found
initial expression of endocrine progenitor marker insm1 in the dorsal
endoderm at stage 32 to be normal in Brunol1morphants, while at later
Fig. 9. Proposed mechanism of BrunoL1 regulation of translation. (A) Generic closed loop model of translation. In this example, PABP (Poly(A) binding protein) binds long poly(A)
tails and interacts directly with eIF4G, which then binds eIF4E leading to the recruitment of the 40S ribosome and active translation. (B) In Drosophila, Bruno (light pink) binds BREs
(orange rectangles) located in the 3′UTR of oskar or cyclin AmRNAs to repress translation. It does this by interacting with Cup (through its linker domain); Cup in turn binds eIF4E
preventing it from interacting with eIF4G, and thus blocking translation. The 3 RRMs and Linker region are shown separately to illustrate that Bruno binds 3 BREs. (C,D) Two
proposed models for how BrunoL1 may lead to increased translation. In both models the 3 RRM domains of BrunoL1 bind the 3 BRE sites in the 3′UTR of cyclin A2 mRNA. Then
BrunoL1 interacts (via the linker domain) either directly with eIF4G or through an intermediate protein (protein X) that binds eIF4G. By bringing eIF4G into close proximity with
eIF4E, the two proteins can bind leading to the recruitment of the 40S ribosome and stimulation of translation.
167L.D. Horb, M.E. Horb / Developmental Biology 345 (2010) 156–169stages its expression was absent. This difference is reﬂective of the fact
that loss of BrunoL1 does not block differentiation of the ﬁrst born
endocrine cells (beta cells), but does block later endocrine cells, both in
the pancreas and the gastrointestinal tract. The differences seen with
Insm1 can be explained by the fact that insm1 is only expressed after
endodermal cells have proliferated and cell fate established. Since beta
cell fate andproliferation is regulated at anearlier stage, prior tobrunol1
expression and thus independent of brunol1, initial expression of insm1
is therefore unaffected.
We believe BrunoL1 is expressed in endodermal progenitors and
controls their proliferation, beginning from NF32. If BrunoL1 is indeed
expressed in endodermal progenitor cells, then its loss of functionshould affect differentiation of all endodermal cells, and this is exactly
what we see. Only after stage 30 does loss of BrunoL1 have any effect
on endoderm development. BrunoL1 acts to control proliferation after
organ domains have been speciﬁed, but prior to cell fate determina-
tion. Thus proliferation of endodermal cells occurs after speciﬁcation
of organ domains, but prior to cell fate determination.
Linker domain and regulation of translation
One of the key ﬁndings of our data was that the linker domain was
both necessary and sufﬁcient for BrunoL1 function. Given that the
RRM domains garner most of the attention this result was surprising
168 L.D. Horb, M.E. Horb / Developmental Biology 345 (2010) 156–169though not entirely unexpected. It was previously shown that
Drosophila Bruno interacted with Cup through its linker domain
(Nakamura et al., 2004). Since Bruno family members bind similar
RNA sequences via their RRM domains (Good et al., 2000) this implies
that speciﬁcity for function resides in the Linker region. Coupled with
the fact that the linker domain of BrunoL1 is unique (i.e. does not
show high amino acid sequence similarity with other members) our
hypothesis is that this linker domain regulates translational enhance-
ment function to BrunoL1 (Fig. 9). In agreement with this, we found
that replacement of the linker domain of BrunoL2 with the BrunoL1
linker region conferred BrunoL2 the ability to increase translation
through the cyclin A2 3′UTR.
The linker region has also been shown to be important for the
ability of other RNA binding domain proteins to increase translation.
For example, the ability of HuD, a member of the ELAV family of RNA
binding domain proteins, to stimulate translation is dependent on its
linker domain (Fukao et al., 2009). Similarly, the ability of BrunoL2
(CUGBP1) to increase translation via GC-rich sequences in the 5′
regions of p21 and C/EBPβ is dependent upon the phosphorylation of
Ser-302, which is located in its Linker domain of CUGBP1 (Iakova
et al., 2004; Timchenko et al., 1999, 2006). However, different
mechanisms are used by each protein — CUGBP1 binds eIF2, while
HuD binds eIF4A. Whether BrunoL1 interacts with either of these
proteins has yet to be determined. The fact that the amino acid
sequence of the linker domain of BrunoL1 is not similar to either
CUGBP1 or HuD linker domains suggests that it binds different
proteins to stimulate translation, either directly with eukaryotic
translation initiation factors or through an intermediate (Figs. 9C, D).
Our demonstration that BrunoL1 can increase translation of mRNAs
may explain the results obtained in planarians where a bruno-like gene
(bruli) was found essential for stem cell (neoblasts) maintenance (Guo
et al., 2006). Although nomechanismwas described to account for their
phenotype, they speculated that bruli might function to repress
translation of speciﬁc targets. In light of our data we would argue that
bruli function in neoblasts is to enhance translation of speciﬁc target
mRNAs involved in the regulation of proliferation. Indeed, itmay be that
this is a common mechanism (i.e. increasing translation of cell cycle
components) usedby other Bruno-like proteins to regulate proliferation
of progenitor and stem cells in other tissues.
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